CAS OpenIR  > 生化工程国家重点实验室
Cross-Linking of Thiolated Paclitaxel-Oligo(p-phenylene vinylene) Conjugates Aggregates inside Tumor Cells Leads to "Chemical Locks" That Increase Drug Efficacy
Zhou, Lingyun1,2; Lv, Fengting1,2; Liu, Libing1,2; Shen, Guizhi3; Yan, Xuehai3; Bazan, Guillermo C.4,5; Wang, Shu1,2
2018-03-08
发表期刊ADVANCED MATERIALS
ISSN0935-9648
卷号30期号:10
摘要How to reduce the resistance of certain tumor cells to paclitaxel (PTX) and related taxoid anticancer drugs is a major challenge for improving cure rates. An oligo(p-phenylenevinylene) unit with thiol groups and a PTX unit (OPV-S-PTX), which enhances drug efficacy and reverses resistance is thus designed. The mechanism involves diffusion of OPV-S-PTX into the cell, where pi-pi interactions lead to aggregation. Cross-linking of the aggregates via oxidation of thiol groups is favored in tumor cells because of the higher reactive oxygen species (ROS) concentration. Cross-linked aggregates "chemically lock" the multichromophore particle for a more persistent effect. The IC50 of OPV-S-PTX for tumor cell line A549 is reduced down to 0.33 x 10(-9) M from that observed for PTX itself (41 x 10(-9) M). Enhanced efficacy by OPV-S-PTX is proposed to proceed via acceleration of microtubule bundle formation. A549/T-inoculated xenograft mice experiments reveal suppression of tumor growth upon OPV-S-PTX treatment. Altogether, these results show that the internal cross-linking of OPV-S-PTX through ROS provides a means to discriminate between tumor and healthy cells and the formation of the chemically locked particles enhances drug efficacy and helps in reducing resistance.
关键词Antitumor Assembly Inside Cells Chemical Locks Drug Resistance Supramolecular Paclitaxel
文章类型Article
WOS标题词Science & Technology ; Physical Sciences ; Technology
DOI10.1002/adma.201704888
收录类别SCI
语种英语
关键词[WOS]MEDIATED MULTIDRUG-RESISTANCE ; OVARIAN-CANCER CELLS ; CELLULAR UPTAKE ; BREAST-CANCER ; TAXOL ; TRANSPORTERS ; THERAPY ; CIRCUMVENTION ; NANOPARTICLES ; MICROTUBULES
WOS研究方向Chemistry ; Science & Technology - Other Topics ; Materials Science ; Physics
WOS类目Chemistry, Multidisciplinary ; Chemistry, Physical ; Nanoscience & Nanotechnology ; Materials Science, Multidisciplinary ; Physics, Applied ; Physics, Condensed Matter
项目资助者Strategic Priority Research Program of the Chinese Academy of Sciences(XDA09030306) ; National Natural Science Foundation of China(21373243 ; 91527306 ; 21533012)
WOS记录号WOS:000426720400007
引用统计
被引频次:3[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.ipe.ac.cn/handle/122111/24072
专题生化工程国家重点实验室
作者单位1.Chinese Acad Sci, Beijing Natl Lab Mol Sci, Key Lab Organ Solids, Inst Chem, Beijing 100190, Peoples R China
2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
3.Chinese Acad Sci, State Key Lab Biochem Engn, Inst Proc Engn, Beijing 100190, Peoples R China
4.Univ Calif Santa Barbara, Dept Chem & Biochem, Ctr Polymers & Organ Solids, Santa Barbara, CA 93106 USA
5.Univ Calif Santa Barbara, Dept Mat, Ctr Polymers & Organ Solids, Santa Barbara, CA 93106 USA
推荐引用方式
GB/T 7714
Zhou, Lingyun,Lv, Fengting,Liu, Libing,et al. Cross-Linking of Thiolated Paclitaxel-Oligo(p-phenylene vinylene) Conjugates Aggregates inside Tumor Cells Leads to "Chemical Locks" That Increase Drug Efficacy[J]. ADVANCED MATERIALS,2018,30(10).
APA Zhou, Lingyun.,Lv, Fengting.,Liu, Libing.,Shen, Guizhi.,Yan, Xuehai.,...&Wang, Shu.(2018).Cross-Linking of Thiolated Paclitaxel-Oligo(p-phenylene vinylene) Conjugates Aggregates inside Tumor Cells Leads to "Chemical Locks" That Increase Drug Efficacy.ADVANCED MATERIALS,30(10).
MLA Zhou, Lingyun,et al."Cross-Linking of Thiolated Paclitaxel-Oligo(p-phenylene vinylene) Conjugates Aggregates inside Tumor Cells Leads to "Chemical Locks" That Increase Drug Efficacy".ADVANCED MATERIALS 30.10(2018).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhou, Lingyun]的文章
[Lv, Fengting]的文章
[Liu, Libing]的文章
百度学术
百度学术中相似的文章
[Zhou, Lingyun]的文章
[Lv, Fengting]的文章
[Liu, Libing]的文章
必应学术
必应学术中相似的文章
[Zhou, Lingyun]的文章
[Lv, Fengting]的文章
[Liu, Libing]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。